A comprehensive study involving 1215 patients with breast cancer from the TCGA database revealed that the expression of TLR9 mRNA was generally lower in breast cancer cases compared to normal tissue; however, it was found to be higher in the estrogen-receptor/progesterone-receptor-negative breast cancer cases compared to the control tissue [51]. The gene discussed is TLR9; the disease is breast carcinoma.